The 12th Voge Pharmaceutical Engineering International Forum in 2020 ended successfully at 16:00 pm on September 21. This forum not only attracted many well-known domestic companies to participate in the exhibition, but also attracted many industry elites to come to the exhibition, and the scene was unprecedented. Let us review the wonderful moments in the exhibition together.

In this exhibition, Liu Shilin, Manager of Wiskind Clean R&D Center, started with industry pain points and production needs, and launched a clean room enclosure system solution, and discussed the future development trend of clean room with smart design, environmental friendliness and smart delivery.

Wiskind combines advanced concepts in clean room design and construction, and takes the most concerned domestic topics such as VHP sterilization and nucleic acid testing laboratory design to give detailed explanations on the spot, bringing the audience advanced in pharmaceutical engineering project design and construction. The technology has received unanimous praise, and the scene is unprecedented.

The booth of Wiskind this time was in Booth D301 in Hall W3. With the innovative products independently developed by Wiskind and the professionalism of teamwork, it attracted many exhibitors and won the recognition and support of customers.

In the raging environment of the epidemic, the innovation and upgrading of China's pharmaceutical industry has become the only way for the industry to improve its overall development level. In addition to focusing on R&D and innovation and continuously launching high-quality products, the transformation and upgrading of China's pharmaceutical industry also needs to start with engineering technology and digital factories to promote asepti clean production and GMP standardized operations.

By using advanced technologies and concepts, optimizing production processes, improving production efficiency, reducing costs, and improving overall product quality, China's pharmaceutical industry is promoted toward the goals of innovation and integration, quality compliance, intelligent production, safety and environmental protection. Wiskind will take R&D and innovation as its own responsibility, with high standards and high requirements to help the new development of pharmaceutical engineering.

Finally, I would like to thank everyone for your attention and support to the Wiskind Group, and to have a detailed understanding and recognition of Wiskind’s innovative products through this exhibition, which made the communication and learning during the exhibition more pertinent and purposeful. Gathering is always short, we are about to usher in a parting farewell, but there is a banquet in the world, which is the beginning of the next reunion. See you next time!